Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun 1;17(6):854.
doi: 10.3390/ijms17060854.

Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus

Affiliations
Review

Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus

Enea Gino Di Domenico et al. Int J Mol Sci. .

Abstract

The human herpes virus 8 (HHV-8), also known as Kaposi sarcoma-associated herpes virus (KSHV), can infect endothelial cells often leading to cell transformation and to the development of tumors, namely Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and the plasmablastic variant of multicentric Castleman's disease. KSHV is prevalent in areas such as sub-Saharan Africa and the Mediterranean region presenting distinct genotypes, which appear to be associated with differences in disease manifestation, according to geographical areas. In infected cells, KSHV persists in a latent episomal form. However, in a limited number of cells, it undergoes spontaneous lytic reactivation to ensure the production of new virions. During both the latent and the lytic cycle, KSHV is programmed to express genes which selectively modulate the DNA damage response (DDR) through the activation of the ataxia telangiectasia mutated (ATM) pathway and by phosphorylating factors associated with the DDR, including the major tumor suppressor protein p53 tumor suppressor p53. This review will focus on the interplay between the KSHV and the DDR response pathway throughout the viral lifecycle, exploring the putative molecular mechanism/s that may contribute to malignant transformation of host cells.

Keywords: DNA damage response; cancer; kaposi; sarcoma; skin; tumor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of latency-associated nuclear antigen (LANA)-mediated Kaposi sarcoma-associated herpes virus (KSHV) episomal persistence after infection. LANA binds to LANA binding sequences in the episome terminal repeats by its C terminal region. In this model, γH2AX participates in KHSV episomal persistence possibly by strengthening the interaction between C-LANA and terminal repeat (TR) as proposed by Jha et al., 2013 [45].
Figure 2
Figure 2
LANA and the interacting factors involved in the DNA Damage induction as reported in the text.
Figure 3
Figure 3
Genome instability and DNA damage induction by the KSHV ORF57 as proposed by Jackson et al. 2014 [118]. In a healthy cell, the evolutionarily conserved multiprotein complex hTREX plays a major role during biogenesis and stabilization of the newly transcribed mRNA.

References

    1. De Martel C., Ferlay J., Franceschi S., Vignat J., Bray F., Forman D., Plummer M. Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. Lancet Oncol. 2012;14:607–615. doi: 10.1016/S1470-2045(12)70137-7. - DOI - PubMed
    1. Schottenfeld D., Beebe-Dimmer J. The cancer burden attributable to biologic agents. Ann. Epidemiol. 2015;25:183–187. doi: 10.1016/j.annepidem.2014.11.016. - DOI - PubMed
    1. Cancian L., Hansen A., Boshoff C. Cellular origin of Kaposi’s sarcoma and Kaposi’s sarcoma-associated herpesvirus-induced cell reprogramming. Trends Cell Biol. 2013;23:421–432. doi: 10.1016/j.tcb.2013.04.001. - DOI - PubMed
    1. Rezza G., Tchangmena O.B., Andreoni M., Bugarini R., Toma L., Bakary D.K., Glikoutou M., Sarmati L., Monini P., Pezzotti P., et al. Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sex Transm Dis. 2000;27:159–164. doi: 10.1097/00007435-200003000-00008. - DOI - PubMed
    1. Serraino D., Toma L., Andreoni M., Buttò S., Tchangmena O., Sarmati L., Monini P., Franceschi S., Ensoli B., Rezza G. A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area. Eur. J. Epidemiol. 2001;17:871–876. doi: 10.1023/A:1015678312153. - DOI - PubMed

LinkOut - more resources